Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for fetal growth restriction
IRCT20140317017035N8Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in intrauterine growth restriction (IUGR) comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: Duration of pregnancy. Started Jan 2023; status: completed.
02
Drugs
rosuvastatin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20140317017035N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140317017035N8.